Literature DB >> 16120931

The role of blood-brain barrier permeability in brain tumor imaging and therapeutics.

James M Provenzale1, Srinivasan Mukundan, Mark Dewhirst.   

Abstract

OBJECTIVE: Our purpose is to describe methods of assessing leakiness of the blood-brain barrier and explain mechanisms for exploiting the blood-brain barrier for therapeutic purposes.
CONCLUSION: Knowledge of the workings of the blood-brain barrier is important for an understanding of the ways in which blood-brain barrier permeability may be used as a surrogate marker for drug therapeutic response. Manipulation of the blood-brain barrier may provide a means for selectively targeting tumors for drug delivery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16120931     DOI: 10.2214/ajr.185.3.01850763

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  36 in total

Review 1.  Permeability imaging in pediatric brain tumors.

Authors:  Sandi Lam; Yimo Lin; Peter C Warnke
Journal:  Transl Pediatr       Date:  2014-07

2.  Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas.

Authors:  Na Zhang; Lijuan Zhang; Bensheng Qiu; Li Meng; Xiaoyi Wang; Bob L Hou
Journal:  J Magn Reson Imaging       Date:  2012-05-11       Impact factor: 4.813

3.  Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits.

Authors:  Vera C Keil; Bogdan Pintea; Gerrit H Gielen; Susanne Greschus; Rolf Fimmers; Jürgen Gieseke; Matthias Simon; Hans H Schild; Dariusch R Hadizadeh
Journal:  J Neurooncol       Date:  2017-04-19       Impact factor: 4.130

4.  Impacts of blood-brain barrier in drug delivery and targeting of brain tumors.

Authors:  Yadollah Omidi; Jaleh Barar
Journal:  Bioimpacts       Date:  2012-02-02

5.  Methotrexate-loaded chitosan- and glycol chitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors.

Authors:  Adriana Trapani; Nunzio Denora; Giuliano Iacobellis; Johannes Sitterberg; Udo Bakowsky; Thomas Kissel
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

6.  Assessment of irradiated brain metastases using dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Daniela B Almeida-Freitas; Marco C Pinho; Maria C G Otaduy; Henrique F Braga; Daniel Meira-Freitas; Claudia da Costa Leite
Journal:  Neuroradiology       Date:  2014-03-21       Impact factor: 2.804

Review 7.  Perfusion CT imaging of brain tumors: an overview.

Authors:  R Jain
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-04       Impact factor: 3.825

8.  Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging.

Authors:  Bei Ding; Hua Wei Ling; Ke Min Chen; Hong Jiang; Yan Bo Zhu
Journal:  Neuroradiology       Date:  2006-08-26       Impact factor: 2.804

9.  Usefulness of Contrast-Enhanced 3D-FLAIR MR Imaging for Differentiating Rathke Cleft Cyst from Cystic Craniopharyngioma.

Authors:  M Azuma; Z A Khant; M Kitajima; H Uetani; T Watanabe; K Yokogami; H Takeshima; T Hirai
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-19       Impact factor: 3.825

10.  Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade.

Authors:  R Jain; S K Ellika; L Scarpace; L R Schultz; J P Rock; J Gutierrez; S C Patel; J Ewing; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-17       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.